The contribution of myelin to magnetic susceptibility-weighted contrasts in high-field MRI of the brain

NeuroImage

Volumn 59, Issue 4, 2012, Pages 3967-3975

  Lee, Jongho ^a,b   Shmueli, Karin ^a   Kang, Byeong Teck ^a,c   Yao, Bing ^a   Fukunaga, Masaki ^d   Van Gelderen, Peter ^a   Palumbo, Sara ^e   Bosetti, Francesca ^e   Silva, Afonso C ^a   Duyn, Jeff H ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Chungbuk National University   (South Korea)

^d OSAKA UNIVERSITY   (Japan)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Cuprizone; Demyelination; Formalin fixation; Phase image; R 2 * relaxation; Resonance frequency image; T 2 * decay

Indexed keywords

CUPRIZONE; MYELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRAIN SIZE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATION; FREQUENCY MODULATION; GRAY MATTER; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STAINING; SUSCEPTIBILITY WEIGHTED IMAGING; TISSUE DISTRIBUTION; TISSUE FIXATION; VOXEL BASED MORPHOMETRY; WHITE MATTER;

ANIMALS; BRAIN; DEMYELINATING DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MYELIN SHEATH;

EID: 84857035416     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.10.076     Document Type: Article

References (73)

1. Baxan N., Harsan L.-A., Dragonu I., Merkle A., Hennig J., von Elverfeldt D. Myelin as a primary source of phase contrast demonstrated in vivo in the mouse brain. Proceedings of the 18th Annual Meeting of ISMRM, Stockholm, Sweden 2010, 3016.
2. * in the human brain. NMR Biomed. 2010, 23:1071-1076.
3. Blakemore W. Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J. Neurol. Sci. 1973, 20:63-72.
4. *, phase, and susceptibility weighted contrast. Magn. Reson. Med. 2010, 65:544-550.
5. Chen Z., Johnston L.A., Kwon D.H., Oh S.H., Cho Z.H., Egan G.F. An optimised framework for reconstructing and processing MR phase images. NeuroImage 2010, 49:1289-1300.
6. Chu S.C., Xu Y., Balschi J.A., Springer C.S. Bulk magnetic susceptibility shifts in NMR studies of compartmentalized samples: use of paramagnetic reagents. Magn. Reson. Med. 1990, 13:239-262.
7. Dawe R.J., Bennett D.A., Schneider J.A., Vasireddi S.K., Arfanakis K. Postmortem MRI of human brain hemispheres: T2 relaxation times during formaldehyde fixation. Magn. Reson. Med. 2009, 61:810-818.
8. Denk C., Torres E.H., MacKay A., Rauscher A. The influence of white matter fibre orientation on MR signal phase and decay. NMR Biomed. 2011, 24:246-252.
9. Duyn J.H., van Gelderen P., Li T.Q., de Zwart J.A., Koretsky A.P., Fukunaga M. High-field MRI of brain cortical substructure based on signal phase. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:11796-11801.
10. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2007, Academic Press. 3rd Edition.
11. Fukunaga M., Li T.Q., van Gelderen P., de Zwart J.A., Shmueli K., Yao B., Lee J., Maric D., Aronova M.A., Zhang G. Layer-specific variation of iron content in cerebral cortex as a source of MRI contrast. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3834-3839.
12. Fukunaga M., van Gelderen P., Lee J., Li T.-Q., de Zwart J.A., Merkle H., Matsuda K.M., Matsuura E., Duyn J.H. Investigation of magnetic susceptibility contrast across cortical grey matter and white matter. Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada 2011, 12.
13. Haacke E.M., Xu Y., Cheng Y.C., Reichenbach J.R. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004, 52:612-618.
14. Haacke E.M., Cheng N.Y.C., House M.J., Liu Q., Neelavalli J., Ogg R.J., Khan A., Ayaz M., Kirsch W., Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 2005, 23:1-25.
15. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 1958, 3:41-51.
16. Hammond K.E., Lupo J.M., Xu D., Metcalf M., Kelley D.A.C., Pelletier D., Chang S.M., Mukherjee P., Vigneron D.B., Nelson S.J. Development of a robust method for generating 7.0T multichannel phase images of the brain with application to normal volunteers and patients with neurological diseases. NeuroImage 2008, 39:1682-1692.
17. He X., Yablonskiy D.A. Biophysical mechanisms of phase contrast in gradient echo MRI. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:13558-13563.
18. Hopp K., Popescu B.F.G., McCrea R.P.E., Harder S.L., Robinson C.A., Haacke M.E., Rajput A.H., Rajput A., Nichol H. Brain iron detected by SWI high pass filtered phase calibrated with synchrotron X ray fluorescence. J. Magn. Reson. Imaging 2010, 31:1346-1354.
19. Jenkinson M. Fast, automated, N-dimensional phase-unwrapping algorithm. Magn. Reson. Med. 2003, 49:193-197.
20. Kamman R., Go K., Stomp G., Hulstaert C., Berendsen H. Changes of relaxation times T1 and T2 in rat tissues after biopsy and fixation. Magn. Reson. Imaging 1985, 3:245-250.
21. Lee J., Hirano Y., Fukunaga M., Silva A.C., Duyn J.H. On the contribution of deoxy-hemoglobin to MRI gray-white matter phase contrast at high field. NeuroImage 2010, 49:193-198.
22. Lee J., Shmueli K., Fukunaga M., van Gelderen P., Merkle H., Silva A.C., Duyn J.H. Sensitivity of MRI resonance frequency to the orientation of brain tissue microstructure. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5130-5135.
23. *-based fiber orientation mapping. NeuroImage 2011, 57:225-234.
24. *-weighted MRI of the human brain at 7.0T. NeuroImage 2006, 32:1032-1040.
25. * heterogeneity in human brain white matter. Magn. Reson. Med. 2009, 62:1652-1657.
26. Liu C. Susceptibility tensor imaging. Magn. Reson. Med. 2010, 63:1471-1477.
27. Liu C., Li W., Johnson G.A., Wu B. High-field (9.4T) MRI of brain dysmyelination by quantitative mapping of magnetic susceptibility. NeuroImage 2011, 56:930-938.
28. Luo J., He X., d'Avignon D.A., Ackerman J.J.H., Yablonskiy D.A. Protein-induced water 1H MR frequency shifts: contributions from magnetic susceptibility and exchange effects. J. Magn. Reson. 2010, 202:102-108.
29. Marques J.P., Maddage R., Mlynarik V., Gruetter R. On the origin of the MR image phase contrast: an in vivo MR microscopy study of the rat brain at 14.1T. NeuroImage 2009, 46:345-352.
30. Matsushima G.K., Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 2001, 11:107-116.
31. McMahon E.J., Suzuki K., Matsushima G.K. Peripheral macrophage recruitment in cuprizone-induced CNS demyelination despite an intact blood-brain barrier. J. Neuroimmunol. 2002, 130:32-45.
32. Merkler D., Boretius S., Stadelmann C., Ernsting T., Michaelis T., Frahm J., Brück W. Multicontrast MRI of remyelination in the central nervous system. NMR Biomed. 2005, 18:395-403.
33. Noll D.C., Schneider W. Respiration artifacts in functional brain imaging: sources of signal variation and compensation strategies. Proceedings of the Society of Magnetic Resonance, San Francisco, USA 1994, 647.
34. Norkute A., Hieble A., Braun A., Johann S., Clarner T., Baumgartner W., Beyer C., Kipp M. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus. J. Neurosci. Res. 2009, 87:1343-1355.
35. O'Brien J.S., Sampson E.L. Lipid composition of the normal human brain: gray matter, white matter, and myelin. J. Lipid Res. 1965, 6:537-544.
36. Ogg R.J., Langston J.W., Haacke E.M., Steen R.G., Taylor J.S. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn. Reson. Imaging 1999, 17:1141-1148.
37. Palumbo S., Toscano C., Parente L., Weigert R., Bosetti F. Time-dependent changes in the brain arachidonic acid cascade during cuprizone-induced demyelination and remyelination. Prostaglandins Leukot. Essent. Fatty Acids 2011, 85:29-35.
38. Palumbo S., Toscano C.D., Parente L., Weigert R., Bosetti F. The cyclooxygenase 2 pathway via the PGE2 EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone induced demyelination. J. Neurochem. 2011, (available online). doi:10.1111/j.1471-4159.2011.07363.x.
39. Petridou N., Wharton S.J., Lotfipour A., Gowland P., Bowtell R. Investigating the effect of blood susceptibility on phase contrast in the human brain. NeuroImage 2010, 50:491-498.
40. Pistorio A.L., Hendry S.H., Wang X. A modified technique for high-resolution staining of myelin. J. Neurosci. Methods 2006, 153:135-146.
41. Popko B., Puckett C., Lai E., Shine H.D., Readhead C., Takahashi N. Myelin deficient mice: expression of myelin basic protein and generation of mice with varying levels of myelin. Cell 1987, 48:713-721.
42. Reichenbach J.R., Venkatesan R., Schillinger D.J., Kido D.K., Haacke E.M. Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent. Radiology 1997, 204:272-277.
43. * anisotropy in white matter fibers in marmoset monkeys. NeuroImage 2011, (available online). doi:10.1016/j.neuroimage.2011.08.064.
44. Schäfer A., Wharton S., Gowland P., Bowtell R. Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI. NeuroImage 2009, 48:126-137.
45. * contrast of the cingulum in ultra high fields. Proceedings of the 17th Annual Meeting of ISMRM, Honolulu, Hawaii 2009, 955.
46. Schenck J.F. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med. Phys. 1996, 23:815-850.
47. Schweser F., Deistung A., Lehr B.W., Reichenbach J.R. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med. Phys. 2010, 37:5165-5178.
48. Schweser F., Deistung A., Lehr B., Reichenbach J. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?. NeuroImage 2011, 54:2789-2807.
49. Sedlacik J., Kutschbach C., Rauscher A., Deistung A., Reichenbach J.R. Investigation of the influence of carbon dioxide concentrations on cerebral physiology by susceptibility-weighted magnetic resonance imaging (SWI). NeuroImage 2008, 43:36-43.
50. Sergeant C., Vesvres M., Devès G., Guillou F. Calcium, potassium, iron, copper and zinc concentrations in the white and gray matter of the cerebellum and corpus callosum in brain of four genetic mouse strains. Nucl. Instrum. Methods Phys. Res. B 2005, 231:234-238.
51. Shepherd T.M., Flint J.J., Thelwall P.E., Stanisz G.J., Mareci T.H., Yachnis A.T., Blackband S.J. Postmortem interval alters the water relaxation and diffusion properties of rat nervous tissue-implications for MRI studies of human autopsy samples. NeuroImage 2009, 44:820-826.
52. Shepherd T.M., Thelwall P.E., Stanisz G.J., Blackband S.J. Aldehyde fixative solutions alter the water relaxation and diffusion properties of nervous tissue. Magn. Reson. Med. 2009, 62:26-34.
53. Shmueli K., de Zwart J.A., van Gelderen P., Li T.Q., Dodd S.J., Duyn J.H. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn. Reson. Med. 2009, 62:1510-1522.
54. Shmueli K., Dodd S.J., Li T.Q., Duyn J.H. The contribution of chemical exchange to MRI frequency shifts in brain tissue. Magn. Reson. Med. 2011, 65:35-43.
55. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004, 23:S208-S219.
56. Song S.K., Yoshino J., Le T.Q., Lin S.J., Sun S.W., Cross A.H., Armstrong R.C. Demyelination increases radial diffusivity in corpus callosum of mouse brain. NeuroImage 2005, 26:132-140.
57. Stidworthy M.F., Genoud S., Suter U., Mantei N., Franklin R.J.M. Quantifying the early stages of remyelination following cuprizone induced demyelination. Brain Pathol. 2003, 13:329-339.
58. Sun S.W., Liang H.F., Trinkaus K., Cross A.H., Armstrong R.C., Song S.K. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn. Reson. Med. 2006, 55:302-308.
59. Thelwall P.E., Shepherd T.M., Stanisz G.J., Blackband S.J. Effects of temperature and aldehyde fixation on tissue water diffusion properties, studied in an erythrocyte ghost tissue model. Magn. Reson. Med. 2006, 56:282-289.
60. Tovi M., Ericsson A. Measurements of T1 and T2 over time in formalin-fixed human whole-brain specimens. Acta Radiol. 1992, 33:400-404.
61. White A.R., Reyes R., Mercer J.F.B., Camakaris J., Zheng H., Bush A.I., Multhaup G., Beyreuther K., Masters C.L., Cappai R. Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice. Brain Res. 1999, 842:439-444.
62. * contrast at 7 T: a direct demonstration. Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Canada 2008, 237.
63. * in white matter by extreme rotation of the human head at 7T. Proceedings of the 19th Annual Meeting of ISMRM, Montreal, Canada 2011, 13.
64. Wu Q.Z., Yang Q., Cate H.S., Kemper D., Binder M., Wang H.X., Fang K., Quick M.J., Marriott M., Kilpatrick T.J. MRI identification of the rostral caudal pattern of pathology within the corpus callosum in the cuprizone mouse model. J. Magn. Reson. Imaging 2008, 27:446-453.
65. Wu Z., Mittal S., Kish K., Yu Y., Hu J., Haacke E.M. Identification of calcification with MRI using susceptibility weighted imaging: a case study. J. Magn. Reson. Imaging 2009, 29:177-182.
66. Yablonskiy D.A., Haacke E.M. Theory of NMR signal behavior in magnetically inhomogeneous tissues: the static dephasing regime. Magn. Reson. Med. 1994, 32:749-763.
67. Yang H.J., Wang H., Zhang Y., Xiao L., Clough R.W., Browning R., Li X.M., Xu H. Region-specific susceptibilities to cuprizone-induced lesions in the mouse forebrain: implications for the pathophysiology of schizophrenia. Brain Res. 2009, 1270:121-130.
68. Yao B., Li T.Q., Gelderen P.V., Shmueli K., de Zwart J.A., Duyn J.H. Susceptibility contrast in high field MRI of human brain as a function of tissue iron content. NeuroImage 2009, 44:1259-1266.
69. Yong Hing C.J., Obenaus A., Stryker R., Tong K., Sarty G.E. Magnetic resonance imaging and mathematical modeling of progressive formalin fixation of the human brain. Magn. Reson. Med. 2005, 54:324-332.
70. Zaaraoui W., Deloire M., Merle M., Girard C., Raffard G., Biran M., Inglese M., Petry K.G., Gonen O., Brochet B. Monitoring demyelination and remyelination by magnetization transfer imaging in the mouse brain at 9.4T. MAGMA 2008, 21:357-362.
71. Zhang J., Jones M.V., McMahon M.T., Mori S., Calabresi P.A. In vivo and ex vivo diffusion tensor imaging of cuprizone induced demyelination in the mouse corpus callosum 2011, Magn. Reson. Med, (available online). doi:10.1002/mrm.23032.
72. Zhong K., Leupold J., von Elverfeldt D., Speck O. The molecular basis for gray and white matter contrast in phase imaging. NeuroImage 2008, 40:1561-1566.
73. Zhong K., Ernst T., Buchthal S., Speck O., Anderson L., Chang L. Phase contrast imaging in neonates. NeuroImage 2011, 55:1068-1072.